These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7151578)

  • 1. [Changes in the cerebrospinal fluid pH in nervous system diseases].
    Zhang CG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):167-9. PubMed ID: 7151578
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebrospinal fluid serotonin levels in various organic diseases of the nervous system].
    Makarov AIu; Sachkova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(12):1797-802. PubMed ID: 5602214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebrospinal fluid concentration of glutamine and glutamic acid in true epilepsy and several other diseases of central nervous system].
    Rabinovich PD; Mel'nichuk PV; Katsuk LI
    Vopr Med Khim; 1972; 18(4):367-71. PubMed ID: 4661841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes of cerebrospinal-fluid phospholipids in various neurologic diseases].
    Kovarík J; Votruba M; Sakarová V; Rouchal J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):259-63. PubMed ID: 305647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Spectrophotometric analysis of cerebrospinal fluid pigments with special emphasis on fluid in cerebrovascular insult].
    Parag-Nikolić M; Hlavka V; Barac B; Arko K
    Acta Med Iugosl; 1980; 34(3):251-62. PubMed ID: 7468304
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty acid changes of cerebrospinal fluid in neurological disorders as an index of changes in the blood-brain barrier.
    Pazzagli A; Arnetoli G; Pepeu I; Amaducci LA
    Neurology; 1970 Aug; 20(8):783-6. PubMed ID: 5465848
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-glucuronidase activity in serum, cerebrospinal fluid and urine in normal subjects and in neurological and mental patients.
    Plum CM
    Enzymol Biol Clin (Basel); 1967; 8(2):97-112. PubMed ID: 6031541
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive latex agglutination test on the cerebrospinal fluid. Preliminary communication.
    Lund-Olesen K
    Dan Med Bull; 1969 Feb; 16(2):46-7. PubMed ID: 5309011
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.
    Hare TA
    Mol Cell Biochem; 1981 Sep; 39():297-304. PubMed ID: 7031462
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the origin and the activity of ornithine-carbamoyltransferase in cerebrospinal fluid in neurological-psychiatric diseases].
    Kluge H; Wieczorek V; Unger F; Greger J
    Psychiatr Neurol (Basel); 1967; 154(2):88-94. PubMed ID: 6053460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium in cerebrospinal fluid].
    DOS REIS FILHO I; DOS REIS JB; BEI A
    Arq Neuropsiquiatr; 1957 Mar; 15(1):15-26. PubMed ID: 13445531
    [No Abstract]   [Full Text] [Related]  

  • 12. Citrate studies in some neurological disorders.
    Mascreen M; Snehalata C; Valmikinathan K
    Neurol India; 1973 Mar; 21(1):37-40. PubMed ID: 4764480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the transaminase activity of the cerebrospinal fluid in patients with neurological and psychiatric diseases; report on 297 cases].
    FIESCHI C; SORIANI S
    Sist Nerv; 1958; 10(6):457-74. PubMed ID: 13659100
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of dopamine-releasing protein (DARP) in cerebrospinal fluid of patients with neurological disorders.
    Verdugo-Diaz L; Morgado-Valle C; Solis-Maldonado G; Drucker-Colin R
    Arch Med Res; 1997; 28(4):577-81. PubMed ID: 9428587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid eicosanoids as an index of cerebrovascular status.
    White RP
    Ann N Y Acad Sci; 1989; 559():131-45. PubMed ID: 2672939
    [No Abstract]   [Full Text] [Related]  

  • 16. Entry of tromethamine into the cerebrospinal fluid of humans after cerebrovascular events.
    Nau R; Desel H; Lassek C; Kolenda H; Prange H
    Clin Pharmacol Ther; 1999 Jul; 66(1):25-32. PubMed ID: 10430106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Further observations on the determination of transaminase activity in the cerebrospinal fluid of neurological and psychiatric patients].
    FIESCHI C; SORIANI S
    Boll Soc Ital Biol Sper; 1958 Sep; 34(18):1091-3. PubMed ID: 13607676
    [No Abstract]   [Full Text] [Related]  

  • 18. Taurocyamine in cerebrospinal fluid of neurological and psychiatric patients.
    Wiechert P; De Deyn P; Marescau B; Lowenthal A
    J Neurol Neurosurg Psychiatry; 1986 Jun; 49(6):716-7. PubMed ID: 3734830
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of ammonia in cerebrospinal fluid using the indophenol direct method.
    Huizenga JR; Teelken AW; Tangerman A; de Jager AE; Gips CH; Jansen PL
    Mol Chem Neuropathol; 1998; 34(2-3):169-77. PubMed ID: 10327416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-trace protein concentration in CSF in neurological disorders.
    Link H; Olsson JE
    Acta Neurol Scand; 1972; 48(1):57-68. PubMed ID: 4623111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.